Literature DB >> 21720384

The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network.

M Fareh1, L Turchi, V Virolle, D Debruyne, F Almairac, S de-la-Forest Divonne, P Paquis, O Preynat-Seauve, K-H Krause, H Chneiweiss, T Virolle.   

Abstract

Glioblastoma multiforme (GBM) is the most common form of primary brain tumor in adults, often characterized by poor survival. Glioma-initiating cells (GiCs) are defined by their extensive self-renewal, differentiation, and tumor initiation properties. GiCs are known to be involved in tumor growth and recurrence, and in resistance to conventional treatments. One strategy to efficiently target GiCs in GBM consists in suppressing their stemness and consequently their tumorigenic properties. In this study, we show that the miR-302-367 cluster is strongly induced during serum-mediated stemness suppression. Stable miR-302-367 cluster expression is sufficient to suppress the stemness signature, self-renewal, and cell infiltration within a host brain tissue, through inhibition of the CXCR4 pathway. Furthermore, inhibition of CXCR4 leads to the disruption of the sonic hedgehog (SHH)-GLI-NANOG network, which is involved in self-renewal and expression of the embryonic stem cell-like signature. In conclusion, we demonstrated that the miR-302-367 cluster is able to efficiently trigger a cascade of inhibitory events leading to the disruption of GiCs stem-like and tumorigenic properties.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21720384      PMCID: PMC3263498          DOI: 10.1038/cdd.2011.89

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  37 in total

1.  Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

Authors:  Mitomu Kioi; Hannes Vogel; Geoffrey Schultz; Robert M Hoffman; Griffith R Harsh; J Martin Brown
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  Dynamic distribution and stem cell characteristics of Sox1-expressing cells in the cerebellar cortex.

Authors:  Joelle Alcock; Virginie Sottile
Journal:  Cell Res       Date:  2009-10-13       Impact factor: 25.617

Review 3.  Patents related to cancer stem cell research.

Authors:  Wei Wu
Journal:  Recent Pat DNA Gene Seq       Date:  2010-01

4.  Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.

Authors:  Moneeb Ehtesham; Charles B Stevenson; Reid C Thompson
Journal:  Neurosurgery       Date:  2008-10       Impact factor: 4.654

5.  Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer.

Authors:  C D Salcido; A Larochelle; B J Taylor; C E Dunbar; L Varticovski
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

6.  CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors.

Authors:  Cristina Patru; Luciana Romao; Pascale Varlet; Laure Coulombel; Eric Raponi; Josette Cadusseau; François Renault-Mihara; Cécile Thirant; Nadine Leonard; Alain Berhneim; Maria Mihalescu-Maingot; Jacques Haiech; Ivan Bièche; Vivaldo Moura-Neto; Catherine Daumas-Duport; Marie-Pierre Junier; Hervé Chneiweiss
Journal:  BMC Cancer       Date:  2010-02-24       Impact factor: 4.430

7.  The miR-430/427/302 family controls mesendodermal fate specification via species-specific target selection.

Authors:  Alessandro Rosa; Francesca M Spagnoli; Ali H Brivanlou
Journal:  Dev Cell       Date:  2009-04       Impact factor: 12.270

8.  CXCL12/CXCR4 promotes motility and proliferation of glioma cells.

Authors:  Anália do Carmo; Inês Patricio; Maria T Cruz; Helena Carvalheiro; Catarina R Oliveira; Maria C Lopes
Journal:  Cancer Biol Ther       Date:  2010-01-17       Impact factor: 4.742

Review 9.  Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link?

Authors:  Isabelle Germano; Victoria Swiss; Patrizia Casaccia
Journal:  Neuropharmacology       Date:  2010-01-01       Impact factor: 5.250

10.  CXCR4 mediates the proliferation of glioblastoma progenitor cells.

Authors:  Moneeb Ehtesham; Khubaib Y Mapara; Charles B Stevenson; Reid C Thompson
Journal:  Cancer Lett       Date:  2008-11-12       Impact factor: 8.679

View more
  86 in total

1.  Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients.

Authors:  Candace M Howard; Jagan Valluri; Anthony Alberico; Terrence Julien; Rida Mazagri; Robert Marsh; Hoyt Alastair; Antonio Cortese; Michael Griswold; Wanmei Wang; Krista Denning; Linda Brown; Pier Paolo Claudio
Journal:  Transl Oncol       Date:  2017-02-12       Impact factor: 4.243

2.  MiR-302c-3p suppresses invasion and proliferation of glioma cells via down-regulating metadherin (MTDH) expression.

Authors:  Yonghong Wang; Yujun Wei; Haibo Tong; Laizhao Chen; Yimin Fan; Yuchen Ji; Wenqing Jia; Dongkang Liu; Guihuai Wang
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

Review 3.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

4.  Reactive oxygen species mediate microRNA-302 regulation of AT-rich interacting domain 4a and C-C motif ligand 5 expression during transitions between quiescence and proliferation.

Authors:  Maneesh G Kumar; Neil M Patel; Adam M Nicholson; Amanda L Kalen; Ehab H Sarsour; Prabhat C Goswami
Journal:  Free Radic Biol Med       Date:  2012-06-23       Impact factor: 7.376

Review 5.  Micro-masters of glioblastoma biology and therapy: increasingly recognized roles for microRNAs.

Authors:  Desiree Floyd; Benjamin Purow
Journal:  Neuro Oncol       Date:  2014-04-10       Impact factor: 12.300

6.  Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.

Authors:  Yanlei Guan; Ling Chen; Yijun Bao; Chao Pang; Run Cui; Guangyu Li; Jiyuan Liu; Yunjie Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

7.  Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma.

Authors:  Y Zhang; J Kim; A C Mueller; B Dey; Y Yang; D-h Lee; J Hachmann; S Finderle; D M Park; J Christensen; D Schiff; B Purow; A Dutta; R Abounader
Journal:  Cell Death Differ       Date:  2014-01-17       Impact factor: 15.828

8.  miR-367 stimulates Wnt cascade activation through degrading FBXW7 in NSCLC stem cells.

Authors:  Guodong Xiao; Boxiang Zhang; Jinying Meng; Jichang Wang; Chongwen Xu; Shou-Ching Tang; Xiang Li; Jing Zhang; Rui Liang; Hong Ren; Xin Sun
Journal:  Cell Cycle       Date:  2017-11-14       Impact factor: 4.534

9.  Characterization of embryonic stem-like cells derived from HEK293T cells through miR302/367 expression and their potentiality to differentiate into germ-like cells.

Authors:  Long Wang; Haijing Zhu; Jiang Wu; Na Li; Jinlian Hua
Journal:  Cytotechnology       Date:  2013-10-05       Impact factor: 2.058

10.  Peripherally restricted acute phase response to a viral mimic alters hippocampal gene expression.

Authors:  Lindsay T Michalovicz; Gregory W Konat
Journal:  Metab Brain Dis       Date:  2013-12-24       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.